Bridger Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.36M | Sell |
18,778
-22,272
| -54% | -$9.92M | 4.93% | 8 |
|
|
2025
Q1 | $19.9M | Hold |
41,050
| – | – | 9.89% | 2 |
|
|
2024
Q4 | $16.5M | Hold |
41,050
| – | – | 8.88% | 3 |
|
|
2024
Q3 | $19.1M | Hold |
41,050
| – | – | 9.55% | 3 |
|
|
2024
Q2 | $19.2M | Hold |
41,050
| – | – | 9.9% | 3 |
|
|
2024
Q1 | $17.2M | Sell |
41,050
-6,950
| -14% | -$2.91M | 7.74% | 5 |
|
|
2023
Q4 | $19.5M | Buy |
48,000
+5,600
| +13% | +$2.28M | 7.49% | 4 |
|
|
2023
Q3 | $14.7M | Hold |
42,400
| – | – | 5.4% | 9 |
|
|
2023
Q2 | $14.9M | Buy |
+42,400
| New | +$14.9M | 4.95% | 8 |
|
|
2023
Q1 | – | Sell |
-16,468
| Closed | -$4.76M | – | 31 |
|
|
2022
Q4 | $4.76M | Sell |
16,468
-23,304
| -59% | -$6.73M | 1.92% | 18 |
|
|
2022
Q3 | $11.5M | Sell |
39,772
-33,300
| -46% | -$9.64M | 3.48% | 10 |
|
|
2022
Q2 | $20.6M | Sell |
73,072
-9,728
| -12% | -$2.74M | 4.64% | 8 |
|
|
2022
Q1 | $21.6M | Buy |
82,800
+23,400
| +39% | +$6.11M | 3.54% | 13 |
|
|
2021
Q4 | $13M | Buy |
+59,400
| New | +$13M | 1.69% | 22 |
|